Skip to main content
No Priors: Artificial Intelligence | Technology | Startups

From Restoring Sight to Reimagining the Brain, with Max Hodak

31 min episode · 2 min read
·
Max Hodak

Episode

31 min

Read time

2 min

Topics

Startups, Leadership, Marketing

AI-Generated Summary

Key Takeaways

  • Retinal Prosthesis Commercial Pathway: Prima's current approved version addresses hundreds of thousands of patients in the US and Europe, with the next-generation device targeting millions. Pricing precedents in the field run high — a comparable earlier device billed roughly $150,000 per patient, and an approved gene therapy reimburses at nearly $500,000 per eye.
  • Platonic Representation Hypothesis as BCI Signal: AI model internal representations and biological brain neural recordings share measurable geometric alignment. Science Corp uses this alignment constructively — matching animal brain recordings to AI model activations — as evidence that large AI models are converging on a true underlying data structure, not a performance ceiling.
  • Brain-as-Computer Framework for Medical Device Development: Treating the brain as a computational system rather than a biological mystery produces faster, more predictable clinical results than small-molecule drug discovery. Deep brain stimulation and motor cortex implants can produce functional outcomes within an hour of activation, a timeline no drug trial can match.
  • Cognitive Bottleneck Limits Brain-Keyboard Products: Independent evidence triangulates human conscious information throughput at roughly 10 bits per second — demonstrated by memory recall experiments over Manhattan helicopter rides. Hodak argues this bottleneck means BCI-to-AI communication products offer marginal gains over typing or speech, making them a lower-priority product category.
  • Substrate Independence as the Unifying Mission: Science Corp's three-program pipeline — retinal prosthesis, biohybrid neural interfaces using engrafted living neurons, and perfusion medicine — targets a 10-to-15-year horizon. The goal is reducing biological fragility by making the brain's computational substrate separable from the body's organ systems, starting with vision and expanding to cardiovascular and cancer vulnerabilities.

What It Covers

Max Hodak, founder and CEO of Science Corp and former Neuralink co-founder, discusses Prima, a subretinal prosthesis chip that received European marketing approval in July 2024, the computational framework for understanding the brain, and Science Corp's long-term roadmap toward substrate independence for human consciousness.

Key Questions Answered

  • Retinal Prosthesis Commercial Pathway: Prima's current approved version addresses hundreds of thousands of patients in the US and Europe, with the next-generation device targeting millions. Pricing precedents in the field run high — a comparable earlier device billed roughly $150,000 per patient, and an approved gene therapy reimburses at nearly $500,000 per eye.
  • Platonic Representation Hypothesis as BCI Signal: AI model internal representations and biological brain neural recordings share measurable geometric alignment. Science Corp uses this alignment constructively — matching animal brain recordings to AI model activations — as evidence that large AI models are converging on a true underlying data structure, not a performance ceiling.
  • Brain-as-Computer Framework for Medical Device Development: Treating the brain as a computational system rather than a biological mystery produces faster, more predictable clinical results than small-molecule drug discovery. Deep brain stimulation and motor cortex implants can produce functional outcomes within an hour of activation, a timeline no drug trial can match.
  • Cognitive Bottleneck Limits Brain-Keyboard Products: Independent evidence triangulates human conscious information throughput at roughly 10 bits per second — demonstrated by memory recall experiments over Manhattan helicopter rides. Hodak argues this bottleneck means BCI-to-AI communication products offer marginal gains over typing or speech, making them a lower-priority product category.
  • Substrate Independence as the Unifying Mission: Science Corp's three-program pipeline — retinal prosthesis, biohybrid neural interfaces using engrafted living neurons, and perfusion medicine — targets a 10-to-15-year horizon. The goal is reducing biological fragility by making the brain's computational substrate separable from the body's organ systems, starting with vision and expanding to cardiovascular and cancer vulnerabilities.

Notable Moment

Hodak challenges the common assumption that pre-verbal thought is richer than language. He argues the feeling of having a fully formed idea before writing it down is a cognitive illusion — and that sitting down to write is itself the thinking process, not a translation of it.

Know someone who'd find this useful?

Episode Transcript

The brain very literally, very clearly, plainly is a computer. You can solve computational problems by arranging matter in a certain way and then, like, taking your hands off and pressing go. We talk about being a brain in a vat. That's what the skull is. Like, the brain is connected to the environment through a small number of wires, the cranial and spinal nerves. These little cables that carry your interaction with the world. If you can get the visual signal, auditory signal, balance, motor, in and out of the brain, that is an end in itself. That is the central object. The retinal prosthesis right now, I think, is a great proof of concept that we're on the right track. Nobody had previously ever been able to restore a form vision image in the mind's eye of a of a blind patient in this way. We need to add depth of grayscale. We think we could see a path to get at least red and green. And so there's ways that we can compound upon this path through an engineering process to make a product that's better and better. Hi, listeners. Welcome back to no priors. Today, I'm here with Max Hodak, the founder and CEO of CYENS, formerly of Neuralink. We talk about Prima, the implant that helps people who have gone blind see again, which just got regulatory approval in Europe. Their quest to sustain the human experience and substrate independence for the brain. We also talk about alignable representations between AI models and the future of neuroscience. Welcome, Max. Max, thanks so much for doing this. Thanks for having me. So for anyone who is not familiar with science, can you just describe a little bit about, you know, why you start the company, leaving Neuralink, what the mission is? Fundamentally, we're a medical device company. But I think if, like, the mission of lowercase s science is to use a differentiated understanding of the universe to improve the human condition, I mean, that's that's the mission of uppercase s science. That's what we do. We use, specifically an understanding of how to work with the brain to get big effect sizes that you don't get in medicine often. Our main product is a retinal prosthesis. You can think of it like a cochlear implant for the eye. Cochlear implants are some of the biggest impacts in in all of medicine. I mean, you can if you've ever seen a video of a newborn turning on, turning it on for the first time, it's striking. And our goal is to to build things like that, including our primo retinal prosthesis. And for people who are not familiar with that, it's a chip Yes. That's inserted with glasses. It's so it's a tiny chip that's implanted under the retina in the back of the eye for patients that have gone blind due to loss of the light sensitive cells in the eye. So, specifically, this is …

Get the full transcript (6,323 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all No Priors: Artificial Intelligence | Technology | Startups transcripts →

You just read a 3-minute summary of a 28-minute episode.

Get No Priors: Artificial Intelligence | Technology | Startups summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from No Priors: Artificial Intelligence | Technology | Startups

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best AI Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Startups & Product Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into No Priors: Artificial Intelligence | Technology | Startups.

Every Monday, we deliver AI summaries of the latest episodes from No Priors: Artificial Intelligence | Technology | Startups and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime